Dutch government shakes up healthcare financing
This article was originally published in Clinica
The Dutch government is making fundamental changes to the way healthcare is financed by giving private healthcare insurers a more important role. It plans to phase out public insurers and use private funds to deliver both a basic, government-regulated healthcare package, and supplementary services paid for by the patient.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.